ReWalk, Myomo could benefit from proposed new Medicare rule
The MyoPro (left) and Personal Exoskeleton (right) could benefit from a proposed Medicare ruling. [Images from ReWalk Robotics and Myomo] A new proposed rule from the Centers for Medicare and Medicaid Services (CMS) could benefit companies like ReWalk Robotics (Nasdaq:RWLK) and Myomo (NYSE:MYO). The proposed rule would establish a new regulatory definition of “brace.” In…